Literature DB >> 8904523

Defective interferon-gamma production by T-lymphocytes from patients with acute brucellosis.

M Rodriguez-Zapata1, I Salmeron, L Manzano, O J Salmeron, A Prieto, M Alvarez-Mon.   

Abstract

The authors investigated the production of interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) by phytohaemagglutinin (PHA)-stimulated T-lymphocytes from 21 untreated patients with acute brucellosis. PHA-stimulated T-lymphocytes from acute brucellosis patients showed normal IL-2 production but defective IFN-gamma production (brucellosis patients 531 +/- 103 pg mL-1 vs. healthy controls 1024 +/- 212 pg mL-1) after 72 h of culture. This altered pattern of IL-2 and IFN-gamma production by T-lymphocytes was observed in seven brucellosis patients whose T-lymphocytes exhibited a normal proliferative response to PHA (61 612 +/- 18 422 cpm) as well as in the 14 patients with a defective T-lymphocyte proliferative response to the PHA after 5 days of culture (19 479 +/- 4409 cpm). After antibiotic therapy, production of the two lymphokines by the PHA-stimulated T-lymphocytes from acute brucellosis patients was similar to that of T-lymphocytes from healthy control subjects. The authors conclude that PHA-stimulated T-lymphocytes from untreated patients with acute brucellosis have defective INF-gamma production but normal IL-2 production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904523     DOI: 10.1046/j.1365-2362.1996.108250.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  10 in total

1.  Defective reactive oxygen metabolite generation by macrophages from acute brucellosis patients.

Authors:  M Rodriguez-Zapata; E Reyes; L Sanchez; A Espinosa; J Solera; M Alvarez-Mon
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

Review 2.  Alternative strategies for vaccination to brucellosis.

Authors:  David W Pascual; Xinghong Yang; Hongbin Wang; Zakia Goodwin; Carol Hoffman; Beata Clapp
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

3.  Human brucellosis is characterized by an intense Th1 profile associated with a defective monocyte function.

Authors:  Manuel Rodríguez-Zapata; Marlene J Matías; Alfredo Prieto; Marco A Jonde; Jorge Monserrat; Lorenzo Sánchez; Eduardo Reyes; Antonio De la Hera; Melchor Alvarez-Mon
Journal:  Infect Immun       Date:  2010-04-19       Impact factor: 3.441

4.  Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages.

Authors:  A Gross; S Spiesser; A Terraza; B Rouot; E Caron; J Dornand
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

5.  Key immunity characteristics of diverse stages of brucellosis in rural population from Inner Mongolia, China.

Authors:  Yongzhang Zhu; Li Shi; Yige Zeng; Dongri Piao; Yingbo Xie; Juan Du; Meng Gao; Wei Gao; Junli Tian; Jun Yue; Min Li; XiaoKui Guo; Yufeng Yao; YaoXia Kang
Journal:  Infect Dis Poverty       Date:  2022-06-04       Impact factor: 10.485

6.  Liver involvement in patients with brucellosis: results of the Marmara study.

Authors:  D Ozturk-Engin; H Erdem; S Gencer; S Kaya; A I Baran; A Batirel; R Tekin; M K Celen; A Denk; S Guler; M Ulug; H Turan; A U Pekok; G Mermut; S Kaya; M Tasbakan; N Tulek; Y Cag; A Inan; A Yalci; C Ataman-Hatipoglu; I Gonen; A Dogan-Celik; F Bozkurt; S Gulsun; M Sunnetcioglu; T Guven; F Duygu; E Parlak; H Sozen; S Tosun; T Demirdal; E Guclu; O Karabay; N Uzun; O Gunal; H Diktas; A Haykir-Solay; A Erbay; C Kader; O Aydin; A Erdem; N Elaldi; A Kadanali; Z Yulugkural; L Gorenek; M Altındis; S Bolukcu; C Agalar; N Ormeci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-21       Impact factor: 3.267

7.  Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.

Authors:  Paula Barrionuevo; Juliana Cassataro; M Victoria Delpino; Astrid Zwerdling; Karina A Pasquevich; Clara García Samartino; Jorge C Wallach; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

Review 8.  Brucellosis in patients infected with the human immunodeficiency virus.

Authors:  S Moreno; J Ariza; F J Espinosa; D Podzamczer; J M Miró; A Rivero; M Rodríguez-Zapata; J Arrizabalaga; R Mateos; F Herrero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 5.103

9.  Ex vivo innate immune cytokine signature of enhanced risk of relapsing brucellosis.

Authors:  Kristyn E Feldman; Paul M Loriaux; Mayuko Saito; Iskra Tuero; Homarh Villaverde; Tenaya Siva; Eduardo Gotuzzo; Robert H Gilman; Alexander Hoffmann; Joseph M Vinetz
Journal:  PLoS Negl Trop Dis       Date:  2013-09-05

Review 10.  Role of circulating lymphocytes in patients with sepsis.

Authors:  Raul de Pablo; Jorge Monserrat; Alfredo Prieto; Melchor Alvarez-Mon
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.